Every valuation, profitability, balance-sheet and per-share figure DeltaScreener holds for NatureWise Biotech & Medicals Corporation (4732.TWO), each with what it measures. Figures are trailing twelve months or the most recent reported period.
Valuation
Metric
Value
P/E ratioShare price divided by earnings per share.
-5.92
P/B ratioShare price divided by book value per share.
1.42
P/S ratioMarket value divided by annual revenue.
4.54
EV / EBITDAEnterprise value against earnings before interest, tax, depreciation and amortisation.
-3.05
EV / RevenueEnterprise value against annual revenue.
2.86
Earnings yieldEarnings per share as a percentage of the share price — the inverse of P/E.
-16.88%
Profitability
Metric
Value
Gross marginRevenue left after the direct cost of goods sold.
46.53%
Operating marginRevenue left after operating costs.
-106.36%
Net marginRevenue left after every cost, including tax and interest.
-76.55%
Return on equityProfit as a percentage of shareholders’ equity.
-26.83%
Return on assetsProfit as a percentage of total assets.
-14.84%
Financial health
Metric
Value
Current ratioCurrent assets divided by current liabilities. Above 1 means short-term assets cover short-term bills.
7.06
Quick ratioThe same, excluding inventory.
4.97
Debt to equityTotal borrowings against shareholders’ equity.
0.05
Per share and size
Metric
Value
Earnings per shareProfit attributable to each share.
$-2.76
Book value per shareShareholders’ equity divided by shares outstanding.
$11.50
Shares outstandingShares currently issued.
48,456,500
Market capitalisationShare price times shares outstanding.
$792.26M
Enterprise valueMarket value plus net debt — what it would cost to buy the business outright.
$0
EmployeesReported headcount.
32
Dividend
Metric
Value
Dividend yieldAnnual dividend as a percentage of the share price.
0.00%
Payout ratioShare of profit paid out as dividends.
What is NatureWise Biotech & Medicals Corporation's P/E ratio?
NatureWise Biotech & Medicals Corporation (4732.TWO) trades on a price-to-earnings ratio of -5.92. A negative P/E means the company reported a loss, so the ratio is not a meaningful valuation measure.
What is NatureWise Biotech & Medicals Corporation's return on equity?
NatureWise Biotech & Medicals Corporation (4732.TWO) reports a return on equity of -26.83%, meaning it generated that much profit for every dollar of shareholders' equity.
How much debt does NatureWise Biotech & Medicals Corporation carry?
NatureWise Biotech & Medicals Corporation (4732.TWO) has a debt-to-equity ratio of 0.05, which compares total borrowings with shareholders' equity.
What is NatureWise Biotech & Medicals Corporation's profit margin?
NatureWise Biotech & Medicals Corporation (4732.TWO) keeps -76.55% of revenue as net profit after every cost, including tax and interest.